Related Experiment Video
Updated: May 31, 2026
09:43
Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
Published on: August 1, 2025
Kinesin KIF20A Regulated by ATF2 Transcription Promotes Prostate Cancer Proliferation and Invasion
Mengchen Yang1, Xuhan Yao1, Xilei Liu1
1Department of Urology, Tianjin Medical University General Hospital, 300070 Tianjin, China.
Frontiers in Bioscience (Landmark Edition)
|May 30, 2026
Summary
Kinesin-like protein family 20A (KIF20A) is upregulated in prostate cancer, promoting tumor progression. Activating transcription factor 2 (ATF2) drives KIF20A expression, suggesting KIF20A as a prognostic marker.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- The role of kinesin-like protein family 20A (KIF20A) in prostate cancer progression is not well understood.
- Investigating KIF20A's function and regulatory mechanisms is crucial for understanding prostate cancer development.
Purpose of the Study:
- To elucidate the functional role of KIF20A in prostate cancer progression.
- To identify the transcriptional regulatory mechanism of KIF20A involving activating transcription factor 2 (ATF2).
Main Methods:
- Quantitative real-time PCR, western blotting, and immunohistochemistry were used to measure KIF20A expression.
- Prostate cancer cell proliferation and invasion assays were performed after KIF20A knockdown.
- Chromatin immunoprecipitation and dual-luciferase reporter assays validated ATF2 binding to the KIF20A promoter.
Main Results:
- KIF20A expression was significantly higher in prostate cancer tissues than in adjacent non-cancerous tissues.
- Elevated KIF20A expression correlated with advanced tumor grade, stage, and lymph node metastasis.
- KIF20A knockdown suppressed prostate cancer cell proliferation and invasion, while ATF2 was found to promote KIF20A transcription.
Conclusions:
- ATF2 transcriptionally upregulates KIF20A in prostate cancer, driving tumor progression.
- KIF20A may serve as an independent prognostic factor for prostate cancer patients.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:35Cancer Cell Migration through Invadopodia
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:45Destabilization of Microtubules
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...